Factors influencing results of chemotherapy in aggressive lymphomas.

被引：0
|
作者：
Souza, CA [1 ]
Moraes, SL [1 ]
Barbosa, KB [1 ]
Borba, G [1 ]
Regazzo, JT [1 ]
Neto, JPV [1 ]
LorandMetze, I [1 ]
机构：
[1] UNIV ESTADUAL CAMPINAS,DEPT INTERNAL MED,BR-13081970 CAMPINAS,SP,BRAZIL
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3502 / 3502
页数：1
相关论文
共 50 条
  • [41] Rituximab is associated with late onset neutropenia (LON) when administered with doxorubicin-based chemotherapy for the initial treatment of aggressive B-cell lymphomas.
    Dunleavy, KM
    Little, RF
    Grant, N
    White, T
    Wright, G
    Janik, J
    Wilson, WH
    BLOOD, 2003, 102 (11) : 397A - 398A
  • [42] RESULTS OF AGGRESSIVE CHEMOTHERAPY FOR MYELODYSPLASTIC SYNDROMES
    DOHY, H
    KYO, T
    ACTA HAEMATOLOGICA JAPONICA, 1988, 51 (08): : 1428 - 1434
  • [43] Factors that predict response and disease free survival in clinically advanced follicular lymphomas.
    Genua, A
    Biscottini, B
    Cinieri, S
    Trottini, M
    DeRenzo, A
    Rotoli, B
    Tafuto, S
    Abate, G
    Milani, S
    Mustacchi, G
    Ambrosi, L
    Leoni, P
    Mastria, A
    Lorusso, V
    Vecchi, A
    Sacchi, S
    Palmieri, F
    Volpe, E
    Azzolini, C
    Dammacco, F
    DiCostanzo, F
    Caparrotti, G
    Grignani, F
    DeANgelis, V
    AlSharjaby, N
    Liberati, AM
    BLOOD, 1997, 90 (10) : 842 - 842
  • [44] Significant differences of the Standard Uptake Values (SUV) from PET scan between indolent and aggressive lymphomas.
    Parling-Lynch, KJ
    Zakalik, D
    Hwang, R
    Singleton, TP
    Wong, CYO
    BLOOD, 2003, 102 (11) : 270B - 271B
  • [45] p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
    Fest, T
    Hernandez, L
    TeruyaFeldstein, J
    Cazorla, M
    Bosch, F
    Peinado, MA
    Piris, MA
    Montserrat, E
    Cardesa, A
    Jaffe, ES
    Raffeld, M
    Campo, E
    BLOOD, 1995, 86 (10) : 2112 - 2112
  • [46] Molecular characterization of a novel gene, bal, which regulates the proliferation of aggressive B-cell lymphomas.
    Yakushijin, Y
    Aguiar, R
    Steckel, J
    Kharbanda, S
    Freeman, G
    Shipp, MA
    BLOOD, 1997, 90 (10) : 782 - 782
  • [47] TREATMENT OF AGGRESSIVE PRIMARY GASTROINTESTINAL LYMPHOMAS WITH INTENSIVE CHEMOTHERAPY - RESULTS OF LNH-84 REGIMEN FROM THE GELA
    SALLES, G
    HERBRECHT, R
    BRICE, P
    SEBBAN, C
    TILLY, H
    LEDERLIN, P
    BERGER, F
    COIFFIER, B
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1992, 28 (04): : 205 - 208
  • [48] Activation of the endoplasmic reticulum (ER) unfolded protein response (UPR) in aggressive B-cell lymphomas.
    Balague, Olga
    Colomo, Luis
    Lopez-Guillermo, Armando
    Campo, Elias
    Martinez, Antonio
    BLOOD, 2006, 108 (11) : 577A - 577A
  • [49] Autologous stem cell transplantation as consolidation of first line response for aggressive non Hodgkin's lymphomas.
    Fanin, R
    Sperotto, A
    Geromin, A
    Cerno, M
    Stocchi, R
    Zaja, F
    Patriarca, F
    Silvestri, F
    Damiani, D
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S158 - S158
  • [50] Radiation therapy's contribution to local control and progression-free survival in patients with aggressive lymphomas.
    Wilder, RB
    Rodriguez, MA
    Tucker, SL
    Ha, CS
    Hess, MA
    Cabanillas, FF
    Cox, JD
    BLOOD, 2000, 96 (11) : 251B - 251B
12345